Skip to main content

TERUMO GLOBAL

Search

Select Region

Show — Select Region Hide — Select Region

- Regions/Countries
  - - Europe
    - Latin America
      - Mexico
        
        Brazil
        
        Colombia
        
        Chile and Argentina
        
        Latin America
  - - Asia Pacific
    - Australia
    - Korea
    - Vietnam
    - China
    - India
- Global Business website

About Terumo
About Terumo
Dear Stakeholders
Terumo Group Identity
Terumo Group Code of Conduct
Corporate Profile
Corporate Governance
Compliance
Procurement Activity
Regulations and Standards
Directors and Executive Officers
History
Our Stories
Terumo's Response to COVID-19
Business Overview
Business Overview
TIS Division (Terumo Interventional Systems)
Neurovascular Division (MicroVention)
Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
Vascular Graft Division (Terumo Aortic)
Hospital Care Solutions Division / Life Care Solutions Division
Pharmaceutical Solutions Division
Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
Sustainability
Sustainability
Sustainability News
Message from Top Management
Sustainability at the Terumo Group
Resolving Healthcare Challenges
Creating a Diverse and Inclusive Workplace
Reducing Environmental Footprint
Serving Our Communities
Report Library
GRI Standards Index
Technology
Technology
Basic Information
Basic Information Top
Research and Development
Production and Supply
Intellectual Property
Terumo Fellows
Stories - Our Technologies
Investors
Investors
Management Policy
Management Policy
Top Management Message
Business Risks
Disclaimer
IR Policy
Financial Highlights
IR Library
IR Library
Financial Statements
Presentations
Consolidated Financial Statements
Terumo Reports
IR Events
Shareholders & Stock
Shareholders Meeting
Stock Information
Shareholder Return
Credit Ratings and Corporate Bond
Analyst Coverage
Articles of Incorporation
Site Quote
IR Inquiries
News
News
May 25, 2022
Corporate
Terumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022
Corporate
Terumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022
Corporate
Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan
Adjunctive use of Blood Glucose Meter Principally Not Required
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Global Network
Global Network
Japan
North America
South America
Europe, Middle East and Africa
Greater China
Asia and Pacific

Breadcrumb

Home
Investors
IR Library
Consolidated Financial Statements

Consolidated Financial Statements

Move to top

Top

FYE 3/2021
FYE 3/2020
FYE 3/2019
FYE 3/2018
FYE 3/2017

FYE 3/2021

Consolidated Financial Statements (PDF 1.46 MB)
FYE 3/2020

Consolidated Financial Statements (PDF 1.48 MB)
FYE 3/2019

Consolidated Financial Statements (PDF 1.52 MB)
FYE 3/2018

Consolidated Financial Statements (PDF 1.77 MB)
FYE 3/2017

Consolidated Financial Statements (PDF 2.93 MB)

Adobe Reader (free) is required to view PDF files.

Download Adobe Reader

Footer Menu

Show — Footer Menu Hide — Footer Menu

- Investors
- News
  - - News
    - Press Inquiries
- Global Network

About Terumo
Business Overview
Sustainability
Technology
Investors
News
Global Network

Footer

Show — Footer Hide — Footer

Terms and Conditions of Use
Privacy Policy
Cookie Policy
Cookie Settings
Social Media Policy
Site Map

Copyright © 2022 Terumo Corporation, All Rights Reserved.